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Edited by Miguel De la RosaAbstract 1H MRS signals of glutathione and of free glutamate
were examined in samples from cultured tumour cells, namely
MCF-7 from mammary carcinoma and TG98 from malignant
glioma, with the aim of relating signal intensities to aspects of
GSH metabolism. Spectra of cells harvested at diﬀerent cell den-
sities suggest that GSH and glu signal intensities are related to
cell density and proliferation and their ratio is dependent on
the activity of the c-glutamyl cysteine synthetase. The hypothesis
is conﬁrmed by experiments performed on cells treated with
buthionine sulfoximine that inhibits the enzyme activity.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: 1H MRS; Glutathione; c-Glutamyl cysteine
synthetase; Tumour cells1. Introduction
The tripeptide c-glutamylcysteinylglycine, Glutathione
(GSH), is a ubiquitous molecule that may act as antitoxic
agent by reacting with both electrophylic or oxidizing species
[1]. The GSH level and metabolism have been invoked as ma-
jor determinants of the eﬃciency of cells in its detoxiﬁcation
action against internal toxic agents that are produced during
cell lifespan as well as external chemical or physical insults [2].
MRS has been employed to study GSH metabolism both
in vitro [3,4] and in vivo [5,6]. 1H MRS signals of GSH and
of its oxidized form GSSG were assigned to speciﬁc chemical
groups through 1D and 2D COSY experiments performed in
GSH solution and in perchloric acid extracts from tissues
[4,7,8].
In a previous paper [8], we related the intensity of GSH sig-
nals of tumour cells to cell tendency to undergo apoptosis by
irradiation. In the present study, we examined MRS signal
intensity of GSH and of free glu in cultured cells MCF-7 from
mammary carcinoma and T98G from malignant glioma, aim-
ing at elucidating to which aspects of GSH metabolism they
are related. On the basis of experiments on cells collected at
diﬀerent cell densities and on cells treated with buthionine sul-
foximine (BSO), we found that the cell density and prolifera-
tion are the major determinant of intensities of GSH and of*Corresponding author. Fax: +39 06 49387075.
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doi:10.1016/j.febslet.2007.01.025free glu signals and their ratio is directly related to the activity
of c-glutamyl cysteine synthetase, the rate limiting enzyme in
GSH synthesis.2. Materials and methods
MCF-7 cells were purchased from ATCC (Manassas, VA, USA) and
kindly donated by Dr. Stefania Meschini, Istituto Superiore di Sanita`,
Rome, Italy. Cells were grown, as adherent cells, in RPMI 1640 med-
ium (Hyclone, Logan, Utah) and 1· nonessential aminoacids (Euro
Clone Life Science Division, Milan, Italy). T98G cells were purchased
from the ECACC (Porton Down, Salisbury, Wiltshire, SP4 0JG) and
kindly donated by Dr. Angelica Facoetti of University of Pavia, Italy.
Cells were grown, as adherent cells, in RPMI 1640 medium (Hyclone)
added with 1 mM sodium pyruvate and 1· nonessential amino acids
(Euro Clone Life Science Division). The medium of both cell lines
was supplemented with 10% fetal calf serum (Hyclone) and 50 lg/ml
gentamicin. Cells deriving from both cell lines were routinely seeded
in 175 cm2 ﬂasks at a density of 4 · 105 cells per ﬂask in 50 ml medium.
The medium was replaced every 72 h.
MCF-7 and T98G cells were treated with BSO for 18 h. The medium
was then removed, cells washed and fresh medium added.
GSH solutions were prepared by dissolving GSH in 2H2O to a ﬁnal
concentration of 10 mM and pH adjusted to 7.4.
PCA extracts were prepared as previously described [8].
All reagents were purchased from Sigma (St. Louis, MI, USA).
1D 1HMR spectra were run at 400.14 MHz on a digital Avance spec-
trometer (Bruker, AG, Darmstadt, Germany) equipped with a 1 mm
microprobe. Signals were acquired with a 90 RF pulse and a sweep
width of 4006.4 Hz. The number of scans was 512 with a repetition time
of 4.36 s. Water suppression was obtained by irradiating water signal.
2D 1H COSY spectra of cells were acquired with a 90–tl–90–t2 pulse
sequence, by summing 16 free induction decays for each of 256 incre-
ments in t1. Spectra were acquired as a matrix of 512 · 256 data points
in the time domain. When indicated, a Lorentzian–Gaussian function
with LB = 10 Hz and GB = 0.1 was applied to enhance the resolution
in the time domain before Fourier transformation.
To perform MRS measurements on cells, a pellet of approxi-
mately 5 · 106 cells was suspended in phosphate-buﬀered saline
with 10% 2H2O and inserted in a 1 mm tube.
By considering that (i) the spectral region of interest was well char-
acterized with respect to metabolite peaks; (ii) signals had similar
intensities and linewidths and (iii) the signal to noise ratio was above
10 also for the lowest signals, the ‘‘1D WINNMR’’ software (Bruker)
was considered adequate for spectral deconvolution. A Gaussian/
Lorentzian ratio equal to 1 for the line shape function was chosen.3. Results
Fig. 1 shows the 1H MR spectral regions (4.5–0.5 ppm) of
T98G (a) and of MCF-7 (b) cells. Many signals from mobile
lipids are present in both spectra. Main signals of fatty acidblished by Elsevier B.V. All rights reserved.
(ppm)
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Fig. 1. ID 1H MR spectra (region 4.5–0.5 ppm) of (a) T98G and (b) MCF-7cells. 2D COSY 1H MR spectra (region 4.65–1 ppm) of (a 0) T98G and
(b) MCF-7 cells.
638 S. Grande et al. / FEBS Letters 581 (2007) 637–643chains are at 0.89 ppm from terminal –CH3, at 1.27 ppm from
(–CH2)n bulk, at 1.61 ppm from (–CH2) in position 3, at
2.02 ppm from CH2ACH2ACH‚CH and at 2.32 ppm from
(–CH2) in position 2. Signals from GSH, centred at 2.97
(bCH2 group of cys), 2.55 (cCH2 of glu), 2.17 (bCH2 of glu)
are also intense, particularly in spectra of T98G cells
(Fig. 1a). Signals at 2.35 and at 2.10 ppm are from cCH2
and bCH2 of free glu, respectively. Assignments were con-
ﬁrmed by 2D COSY spectra (Fig. 1a 0,b 0). The correlations
from glu residues in GSH can be found at 2.17–2.55 ppm (b
and c protons) and at 2.17–3.78 ppm (b and a protons). Thecross peak of cys residue in GSH is found at 2.97–4.57 ppm
(b and a protons). Free glu shows the cross peak at 2.10–
2.35 ppm from b and c protons, while the correlation from b
and a protons at 2.10–3.77 ppm partially overlaps to the cor-
responding cross peak of glu in GSH.
To perform signal deconvolutions for evaluating intensities
of signals associated to the GSH metabolism, we compared cell
spectra with those of GSH and of free glu solutions. Fig. 2
shows the 1H MR spectral regions, diagnostic for GSH and
free glu signals, of a T98G cell sample (a), GSH solution (b)
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Fig. 2. (a) Spectrum (region 3.9–1.9 ppm) of T98G cells with (a 0,a00), details of cys and glu of GSH, respectively; (b) spectrum (region 3.9–1.9 ppm) of
10 mM GSH solution with (b 0,b00). details of cys and glu of GSH, respectively; (c) spectrum (region 3.9–1.9 ppm) of 10 mM glu solution.
S. Grande et al. / FEBS Letters 581 (2007) 637–643 6392.97 ppm is shown in more detail in Fig. 2a 0,a00,b 0,b00. Compar-
ison of GSH signals in cells with GSH signals in solution indi-
cates that the envelope of glu in GSH, resulting from the
coupling pattern of the two protons of cCH2 with the two pro-
tons of bCH2, resonates approximately at the same frequency
in cell and in solution spectra (compare Fig. 2a00,b00). On the
contrary, the cys envelope, resulting from the coupling pattern
of the two protons of bCH2 with the proton of aCH group, is
shifted in cell spectra to higher ﬁelds with respect to the same
signal in GSH solution (compare Fig. 2a 0,b 0).
Peak deconvolution of cell spectra that takes into account
coupling patterns deriving from spectra of GSH and glu solu-
tions, is shown in Fig. 3. The cys peak of GSH was ﬁtted with
ﬁve lines and three further lines at lower ﬁelds (at 3.04, at 3.03
and 3.01 ppm, respectively) were added in both T98G (Fig. 3a)
and MCF7 cell spectra (not shown). On the basis of a compar-
ison with PCA extract spectra (not shown), the signal at
3.04 ppm was attributed to the CH2 of creatine (more intense
in MCF7 than in T98G cells and extracts) and the signal at
3.01 ppm to the eCH2 of Lys (of comparable intensity in the
two cell lines). The signal at 3.03 ppm was not assigned. The
signal of glu of GSH at 2.55 ppm was ﬁtted with eight lines
(Fig. 3b). Fourteen lines were necessary to obtain a good ﬁt
in the interval 1.5–2.5 ppm (Fig. 3c). In particular, quartets
were used to ﬁt the free glu peak at 2.35 ppm and the peak
of glu of GSH at 2.17 ppm while one large peak was used to
ﬁt the envelope centred around 2.10 ppm deriving from the
bCH2 of free glu and gln (the cCH2 of gln is the peak at
2.42 ppm). The peak at 1.9 is from the acetate while the peak
at 1.68 was not assigned. Fig. 3d shows the 0.4–1.20 ppm re-
gion deconvolved with one peak at 0.94 ppm from cytosolic
polypeptides, at 0.89 ppm from cytosolic polypeptides and lip-ids and at 0.7 ppm from cholesterol. Finally, a broad compo-
nent encompassing the deconvolved regions was added.
To measure relative metabolite concentrations, ﬁtted peak
areas in the 1D spectra were referred to the area of the signal
at 0.94 ppm from the methyl group of cytosolic polypeptides.
We indicate with G the relative concentration of GSH in cells
measured by the envelope signal intensity of glu of GSH at
2.55 ppm and with g that of free glu at 2.35 ppm while ‘‘glu-
tot’’ indicates the sum G + g. Furthermore, we indicate with
C the relative concentration of cys of GSH measured from
the envelope signal intensity at 2.97 ppm. Table 1 reports rela-
tive concentrations G, C, g and glutot and ratios G/g and C/G
for a number of samples deriving from cells harvested in log
phase. Notably, C was only 76% of G in MCF-7 cells and
85% of G in T98G cells, pointing to an incomplete visibility
of cys of GSH in cell spectra.
Cell growth slowed down as cell density increased during
progression towards conﬂuent and post conﬂuent state for
both MCF-7 and T98G cells (Fig. 4a,b). G decreased as a func-
tion of the time in culture in both cell lines (Fig. 4a 0,b 0) and its
decrease was accompanied by a parallel decrease of g and glu-
tot while ratios G/g were almost constant up to six days after
seeding (Fig. 4a 0,a00,b 0,b00). Afterwards, in correspondence with
the onset of conﬂuence, g remained almost constant while G
further decreased: consequently, G/g ratios dropped to lower
values (Fig. 4a 0,a00,b 0,b00).
A large spread of G and g values was observed in diﬀerent
samples harvested from MCF-7 and T98G cells in log phase.
Nevertheless, both G and g were linearly dependent on glutot
(Fig. 5a,b) while ratios G/g were almost constant (Fig. 5a 0,b 0).
To clarify to which metabolic steps the signal inten-
sity changes could be attributed, we monitored the eﬀect of
a b








Fig. 3. Spectral deconvolution of a typical 1H MR spectrum of T98G cells: (a) region of cys of GSH; (b) region of glu of GSH; (c) region of free glu;
(d) region of the cytosolic polypeptides. See text for signal assignments.
Table 1
Mean values and standard deviation (in brackets) of relative concen-
trations of glu of GSH (G), free glu (g), glutot = G + g and cys of GSH
(C) as obtained from spectra of MCF-7 and T98G cells (at least 10
independent experiments)
MCF-7 T98G
G 0.74 (0.12) 0.84 (0.25)
g 0.71 (0.19) 0.54 (0.14)
Glutot 1.45 (0.12) 1.38 (0.38)
G/g 1.04 (0.51) 1.54 (0.19)
C 0.56 (0.02) 0.85 (0.15)
C/G 0.78 (0.12) 0.85 (0.15)
Ratios among values are also given. Cells had been harvested in log
phase.
640 S. Grande et al. / FEBS Letters 581 (2007) 637–643inhibiting the activity of c-glutamyl cysteine synthetase on MR
signals. Cell were treated with BSO, that inhibits the enzyme
activity, and Fig. 6 shows a representative experiment of dose
response with BSO concentration ranging from 0.025 to 1 mM.
In MCF-7 cells, treatment with 0.1 mM BSO concentration
produced a decrease of G up to 46% of control sample, paral-
leled by an increase of g (Fig. 6a and Table 2). G decreased fur-
ther in this cell line by increasing BSO concentration to 1 mM,
representing an additional drop of 10% (Fig. 6a and Table 2).
T98G cells were even more sensitive to BSO as G decreased to
16% of control for 0.1 mM BSO concentration: a further 9%
decrease was induced by 1 mM BSO. Also in T98G cells, g in-
creased (Fig. 6b). As a consequence, G/g ratio markedly de-
creased in both cell lines (Fig. 6a 0,b 0). The increase of g did
not compensate completely the decrease of G and, conse-
quently, glutot values were lower in treated with respect tocontrols (Table 2) in both cell lines. Furthermore, BSO treated
samples were characterized by a lower number cells with re-
spect to controls (Table 2).
Analysis of 2D COSY spectra conﬁrmed the behaviour of
the 1D spectra. On the other hand, they were not considered
for evaluating metabolite relative concentrations because cross
peak areas are strongly dependent on relaxation times.4. Discussion
MRS technique is presently employed to monitor GSH con-
centration particularly in in vivo studies [6]. A deep insight into
the meaning of intensity changes of MRS signals associated to
GSH metabolism is therefore of fundamental importance.
With this respect, studies in intact cultured cells that maintain
cells under controlled conditions are a unique tool for high-
lighting aspects of GSH metabolism.
The literature data report decrease of GSH level when cell
density increases [9–11]. Our MRS data conﬁrm the literature
ﬁndings, as the relative concentration of GSH, G, decreased
with time in culture in both MCF-7 and T98G cells (Fig. 4).
These data were completed by the new observation that a com-
parable decrease occurred also for the concentration of free
glu, g, in log phase (Fig. 4). Consequently, the concentration
of total glu, glutot, decreased while ratios G/g remained almost
constant in log phase. G/g was aﬀected only at conﬂuence
(Fig. 4).
In the past, it was not clear whether the decrease of GSH
with cell density increase was due to limited nutrient supply
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Fig. 4. Growth curves of (a) MCF-7 and (b) T98G, respectively, as a function of time (hours, h) from seeding. N indicates the number of cells (·106)
harvested from culture ﬂasks (c/f) and lines are the exponential model for cells in log phase; relative concentrations G of glu in GSH, g of free glu, and
glutot = G + g, as a function of time (hours, h) from seeding for (a 0) MCF-7 and (b 0) T98G cells; G/g ratios as a function of time (hours, h) from
seeding for (c) MCF-7 and (c 0) T98G cells. Lines in a 0,a00,b 0,b00 are merely to guide the eye. Reported values are relative to a single representative






































Fig. 5. Relative concentrations G, of glu of GSH and g of free glu as a function of totglu = G + g concentration in a number of uncorrelated
experiments performed with cells harvested in log phase for (a) MCF-7 and (b) T98G cells (lines are linear regressions); G/g ratios as a function of
totglu concentration in the same experiments, for (a 0) MCF-7and (b 0) T98G cells.
S. Grande et al. / FEBS Letters 581 (2007) 637–643 641of G accompanied by the decrease of g (and therefore of glu-
tot) with cell density in log phase may be attributed to adecrease of the amount of nutrients that cells draw from the

















































Fig. 6. Relative concentrations G, of glu of GSH, C of cys of GSH and g of free glu in BSO treated (a) MCF-7 and (b) T98G cells, as a function of
BSO concentration. G/g ratios as a function of BSO concentration in the same experiments for (a 0) MCF-7and (b 0) T98G cells. Lines in a,a 0,b,b 0 are
merely to guide the eye. Reported values are relative to a single representative experiment.
Table 2
Mean values of relative concentrations of glu of GSH (G), free glu (g) and glutot = G + g obtained from spectra of MCF-7 and T98G cells after
treatment with BSO at the indicated concentrations
MCF-7 MCF-7 0.1 mM BSO tr MCF-7 1 mM BSO tr
N (c/f) 10.5 ± 1 7.1 ± 0.7 8 ± 0.8
G 0.74 ± 0.07 0.34 ± 0.03 0.27 ± 0.03
g 0.71 ± 0.07 0.98 ± 0.1 0.97 ± 0.1
glutot 1.45 ± 0.15 1.27 ± 0.13 0.83 ± 0.08
T98G T98G 0.1 mM BSO tr T98G 1 mM BSO tr
N (c/f) 2.5 ± 0.3 2.2 ± 0.2 1.5 ± 0.2
G 0.49 ± 0.05 0.09 ± 0.009 0.040 ± 0.004
g 0.43 ± 0.04 0.66 ± 0.07 0.64 ± 0.06
glutot 0.92 ± 0.09 0.75 ± 0.08 0.68 ± 0.07
Cells, seeded at a density of 4 · 105 cells per ﬂask, had been BSO treated at the third day in culture and harvested 18 h after treatment. The number
N · 106 of cells per ﬂask (c/f) is also given. Data reported are from one representative experiment for MCF-7 and one for T98G.
642 S. Grande et al. / FEBS Letters 581 (2007) 637–643is unpredictable from one experiment to another (Fig. 5). On
the other hand, constant G/g ratios during cell proliferation
in log phase should reﬂect the constant activity of the enzyme
c-glutamylcysteine synthetase while the decrease of G not
accompanied by a decrease of g and the consequent drop of
G/g observed at conﬂuence (Fig. 4) could be due to lower activ-
ity of this enzyme when cells are less proliferating.
This interpretation is conﬁrmed by the pattern of signal inten-
sity modiﬁcations of MCF-7 and T98G cells after BSO treat-
ment. After inhibiting the activity of the c-glutamylcysteine
synthetase by BSO, in fact, G decrease was accompanied by in-
crease of g with a consequent strong decrease of G/g ratios
(Fig. 6 and Table 2). This eﬀect was dose dependent (Fig. 6
and Table 2) and is due to the lower activity of the c-glutamyl-
cysteine synthetase. This enzyme, being the rate limiting step in
the GSH synthesis, hinders the utilization of glu that cells drawfrom themedium forGSH synthesis.G/g ratio can be, therefore,
utilized as an index of the activity of c-glutamylcysteine synthe-
tase, the rate limiting enzyme in GSH synthesis that is constant
in log phase and declines passing from log to conﬂuent state.
On the other hand, glutot declined slightly as a function of
BSO dose because the increase of g did not compensate the de-
crease of G (Table 2). By observing that the number of cells in
treated samples was slightly lower than in controls (Table 2), a
lower proliferation rate in BSO treated cells can be envisaged,
in agreement with evidences from the literature [12]. The slight
decrease of glutot in BSO-treated cells could be therefore con-
sequence of this decreased proliferation. Cell cycle modiﬁca-
tions linked to lower proliferation after BSO treatment have
been observed in diﬀerent cell systems [13]. Preliminary data
(not shown) indicate a similar behaviour for the cell lines here
examined.
S. Grande et al. / FEBS Letters 581 (2007) 637–643 643Intensity of cys signal is approximately 76% of glu signal in
GSH of MCF-7 cells and 85% in GSH of T98G cells (Table 1).
The cys residue in GSH can be strongly involved in interac-
tions with other molecules: in fact, protein S-glutathionylation
is a well-described phenomenon occurring in a number of rel-
evant physiologically situations [2]. The presence of very
strong interactions that immobilize the cys residue in a pool
of GSH molecules may account for the lack of visibility in
the MR spectra. On the other hand, the chemical shift of the
cys signal is diﬀerent in cell spectra with respect to GSH solu-
tion (Fig. 2), showing that also the visible pool of cys is aﬀected
by some kind of interactions.
The glu residue and the visible cys residue in GSH are af-
fected by treatment with BSO in a twofold manner in both cell
lines (Fig. 6). This result suggests that there are two pools of
GSH in the cell, with one easily depleted by BSO and a second
more resistant. The entity of the two pools depends on the cell
line. This behaviour would conﬁrm the hypothesis of the liter-
ature that a pool of GSH exists, more resistant to BSO treat-
ment, attributed mostly to mitochondrial GSH [14–16].
These evidences, if conﬁrmed in other cell systems, may oﬀer
a new tool for the study of GSH metabolism.
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